Home › Funds › Logos Global Management LP › LBRX

Logos Global Management LP position in LBRX

LB PHARMACEUTICALS INC · Health Care

Logos Global Management LP reported holding 585,000 shares of LBRX (LB PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$19.0M, representing 0.82% of its reported portfolio and ranking #38 among its reported holdings. Logos Global Management LP has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)585.00K sh
Reported value held$18.99M
Portfolio Weight0.82%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Logos Global Management LP's LBRX position evolved

Logos Global Management LP first disclosed a stake in LBRX in Q3 2025 at 1,130,000 shares (US$17.8M). The position peaked in Q4 2025 at 1,200,000 shares, worth US$26.7M. Across 4 filings, Logos Global Management LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 585,000 shares valued at US$19.0M — a reduction of -330,000 shares quarter over quarter.. Notable position changes include a 36% trim in Q2 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 1.13M $17.84M New
Q4 2025 1.20M $26.71M Add
Q1 2026 915.00K $22.56M Reduce
Q2 2026 585.00K $18.99M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LBRX and 13F data

LBRX (LB PHARMACEUTICALS INC) is a Health Care company. 110 other funds we track also report a position in LBRX — the largest reported positions include Deep Track Capital, LP (US$108.8M), RA CAPITAL MANAGEMENT, L.P. (US$71.7M), Trails Edge Capital Partners, LP (US$49.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LBRX

All LBRX fund holders →

FAQ

How long has Logos Global Management LP held LBRX?

Logos Global Management LP has disclosed LBRX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Logos Global Management LP's current position in LBRX?

As of Q2 2026, Logos Global Management LP holds 585.00K shares of LBRX (LB PHARMACEUTICALS INC), valued at $18.99M, representing 0.82% of its reported portfolio and ranking #38.

Has Logos Global Management LP been buying or selling LBRX?

In the latest 13F filing (Q2 2026), Logos Global Management LP reduced its position in LBRX. The position peaked in Q4 2025 at 1.20M shares.

Which other funds hold LBRX?

Other major institutional holders of LBRX include Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., Trails Edge Capital Partners, LP, among 110 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.